10.1007/s13300-020-00984-x 25 JanzenK
At therapeutic oral doses, MB acts as a catalytic electron [] READ ARTICLE The Self-Led Woman If you are in midlife and feel like your body stopped following the rules it used to, this course is for you
The SURPASS-CVOT trial (NCT04255433) will assess the cardiovascular safety of tirzepatide compared to dulaglutide in people with T2D and established atherosclerotic disease [111]
Henry Meds Henry Meds built its reputation on straightforward, no-membership-fee pricing for compounded GLP-1 medications
Scientists from the WHO recently wrote: The approval of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the treatment of obesity creates potential for a transformation of the whole health system that could halt and reverse the global obesity pandemic through prevention and effective integrated management. Growing crisis South Africa is grappling with dual diabetes and obesity epidemics, on top of the HIV and TB epidemics, but is not responding effectively, resulting in high obesity and diabetes-related deaths
The absolute net benefit of attaining 10% weight loss without experiencing worrisome harms over 2 years was equivalent to 104 (95% CI, 100-112) per 1,000 people, Moll and colleagues reported